Showing results (2601-2610 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|October 23, 2009
Glutathione modulation reverses the growth-promoting effect of growth factors, improving the 5-fluorouracil antitumour response in WiDr colon cancer cellsTeodoro Palomares, Marta Caramés, Ignacio García-Alonso, et al.Anticancer Research|October 23, 2009
Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancerYasuhiro Kodera, Hayao Nakanishi, Seiji Ito, et al.Anticancer Research|October 23, 2009
Expression and mutational status of PDGFR in thymic tumoursMichael Meister, Philip Kahl, Thomas Muley, et al.Anticancer Research|October 23, 2009
Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cellsYung-Tsuan Ho, Chi-Cheng Lu, Jai-Sing Yang, et al.Anticancer Research|October 23, 2009
Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinomaYun Yen, Samuel So, Michal Rose, et al.Anticancer Research|October 23, 2009
Methylene blue dye, an accurate dye for sentinel lymph node identification in early breast cancerCarole Mathelin, Sabrina Croce, David Brasse, et al.Anticancer Research|October 23, 2009
Determinants of homocysteine levels in colorectal and breast cancer patientsP Ferroni, R Palmirotta, F Martini, et al.Anticancer Research|October 23, 2009
Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrenceMartin Koskas, Philippe Morice, Chadi Yazbeck, et al.Anticancer Research|October 23, 2009
Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysisMiguel Martín, José Angel García-Sáenz, Maria Luisa Maestro De las Casas, et al.Anticancer Research|October 23, 2009
Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trialBéatrice Weber, Alain Lortholary, Françoise Mayer, et al.Pageof 2,589